This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
General Life Biotechnology Co., Ltd.
General Life Biotechnology Co., Ltd., commonly referred to as GL Biotech, is a leading player in the biotechnology industry, headquartered in Taiwan (TW). Founded in 2001, the company has established a strong presence in major operational regions across Asia and beyond, focusing on innovative solutions in life sciences. GL Biotech specialises in the development and production of high-quality biopharmaceuticals, diagnostic kits, and research reagents. Their unique approach combines cutting-edge technology with rigorous quality control, ensuring that their products meet the highest industry standards. With a commitment to advancing healthcare, General Life Biotechnology has achieved significant milestones, including collaborations with renowned research institutions and a growing portfolio of patented technologies. This positions the company as a notable contender in the global biotechnology market, dedicated to improving patient outcomes through scientific innovation.
DitchCarbon Score
How does General Life Biotechnology Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
General Life Biotechnology Co., Ltd.'s score of 35 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
General Life Biotechnology Co., Ltd.'s reported carbon emissions
In 2022, General Life Biotechnology Co., Ltd., headquartered in Taiwan (TW), reported significant carbon emissions, totalling approximately 5,000,000 kg CO2e across its operations. This figure includes about 499,894 kg CO2e from Scope 1 emissions and approximately 15,642,451 kg CO2e from Scope 2 emissions in Taiwan. Additionally, the company reported about 23,361,109 kg CO2e in Scope 1 and approximately 44,140,186 kg CO2e in Scope 2 emissions from its operations in Vietnam. Globally, the company’s Scope 2 emissions reached approximately 259,464,406 kg CO2e, while in China, Scope 1 emissions were about 17,601,041 kg CO2e and Scope 2 emissions totalled approximately 179,244,725 kg CO2e. Notably, there is no reported data for Scope 3 emissions. Despite the substantial emissions figures, General Life Biotechnology Co., Ltd. has not disclosed specific reduction targets or initiatives as part of its climate commitments. The company is a current subsidiary of Compal Electronics, Inc., which may influence its sustainability strategies and reporting practices. The emissions data and climate initiatives are cascaded from Compal Electronics, Inc., reflecting the broader corporate family’s approach to environmental responsibility. Overall, while General Life Biotechnology Co., Ltd. has made strides in emissions reporting, further clarity on reduction targets and commitments would enhance its sustainability profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | - | - | - |
| Scope 2 | 214,617,990 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
General Life Biotechnology Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
